Pharmaceuticals: exemption from the new tariffs, was a positive surprise
FinTech BizNews Service
Mumbai, April 3, 2025: On April 2, 2025, the United States imposed a 26% reciprocal tariff on all Indian exports, citing existing high Indian tariffs on U.S. goods and aiming to address trade imbalances.
Accoeding to Satish Chandra Aluri, Lemonn Markets Desk, here’s key sectoral Impacts:
Despite the hit, India's tariff rate is lower than that imposed on other Asian nations, such as China (34%), Vietnam (46%) and Thailand (36%), potentially preserving some competitive advantage for Indian exporters. As such, market reaction is more measured compared to sharp losses in global markets.
India is also continuing its discussions with the U.S. for a new trade deal and has expressed willingness to reduce tariffs on $23 billion worth of U.S. imports, aiming to mitigate the impact of the tariffs and address trade imbalances.